You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 17, 2024

Claims for Patent: 9,695,437

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,695,437

Title:	Constitutive photomorphogenesis 1 (COP1) nucleic acid sequence from zea mays and its use thereof
Abstract:	The present invention relates to an isolated COP1 nucleic acid sequence from a maize plant and the isolated COP1 nucleic acid sequence is named as ZmCOP1. The present invention also relates to a method of using the ZmCOP1 nucleic acid sequence to control the shade avoidance response of a crop plant for high density farming and yield enhancement.
Inventor(s):	Cheikh; Nordine (Davis, CA), Deng; Molian (Grover, MO), Miller; Philip W. (Ballwin, MO), Xu; Nanfei (Wildwood, MO)
Assignee:	Monsanto Technology LLC (St. Louis, MO)
Application Number:	14/315,012
Patent Claims:	1. A recombinant DNA construct comprising a COP1 nucleotide sequence encoding a polypeptide having an amino acid sequence that has at least 90% sequence identity to SEQ ID NO: 21, said COP1 nucleotide sequence being operably linked upstream (5') to a heterologous promoter that functions in a plant and downstream (3') to a regulatory element, wherein the polypeptide binds to a COP1 protein. 2. A crop plant comprising the recombinant DNA construct of claim 1. 3. Progeny or seeds comprising the recombinant DNA construct of claim 1. 4. The recombinant DNA construct of claim 1, wherein said promoter comprises a light-inducible promoter. 5. The recombinant DNA construct of claim 4, wherein said promoter is selected from the group consisting of a cab promoter, an ATHB-2 promoter, and a far red light inducible promoter. 6. The recombinant DNA construct of claim 4, wherein said promoter comprises a cab promoter. 7. The recombinant DNA construct of claim 1, wherein said regulatory element comprises an intron. 8. The recombinant DNA construct of claim 7, wherein said intron comprises a hsp70 intron. 9. The recombinant DNA construct of claim 1, wherein said COP1 nucleotide sequence is isolated from a monocot plant. 10. The recombinant DNA construct of claim 9, wherein said COP1 nucleotide sequence is isolated from a rice maize plant.

Details for Patent 9,695,437

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2021-08-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2021-08-29
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2021-08-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.